Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Loredana Bucciarelli"'
Autor:
Maria Elena Lunati, Vincenzo Cimino, Davide Bernasconi, Alessandra Gandolfi, Paola Silvia Morpurgo, Camilla Tinari, Elisa Lazzaroni, Laura Baruffaldi, Milena Muratori, Laura Montefusco, Ida Pastore, Antonio Rossi, Ivano Giuseppe Franzetti, Fabrizio Muratori, Roberto Manfrini, Olga Eugenia Disoteo, Rosa Terranova, Paolo Desenzani, Angela Girelli, Renata Ghelardi, Francesca D’Addio, Moufida Ben Nasr, Cesare Berra, Franco Folli, Loredana Bucciarelli, Paolo Fiorina
Publikováno v:
Pharmacological Research, Vol 199, Iss , Pp 107040- (2024)
Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor and semaglutide, a glucagon-like peptide 1 receptor agonist, have both demonstrated efficacy in glycemic control, reducing blood pressure, body weight, risk of renal and heart failure in type
Externí odkaz:
https://doaj.org/article/896fc8acef4049c186f0bd9af04fa581
Autor:
Maria Elena Lunati, Vincenzo Cimino, Alessandra Gandolfi, Matteo Trevisan, Laura Montefusco, Ida Pastore, Camilla Pace, Nazarena Betella, Giuseppe Favacchio, Monica Bulgheroni, Loredana Bucciarelli, Giulia Massari, Cristina Mascardi, Angela Girelli, Paola Silvia Morpurgo, Franco Folli, Livio Luzi, Marco Mirani, Basilio Pintaudi, Federico Bertuzzi, Cesare Berra, Paolo Fiorina
Publikováno v:
Pharmacological Research, Vol 183, Iss , Pp 106396- (2022)
Background and aims: Sodium-glucose co-transporter-2 inhibitors (SGLT2i) may have important benefits for the elderly with type 2 diabetes (T2D), however some safety concerns still limit their use in patients over 70 years of age. The SOLD study (SGLT
Externí odkaz:
https://doaj.org/article/4a2c41cb4fed45eeadd7317aaca28290
Autor:
Cesare Celeste Berra, Roberto Manfrini, Marco Mirani, Loredana Bucciarelli, Amhed S Zakaria, Sara Piccini, Renata Ghelardi, Maria Elena Lunati, Sylka Rodovalho, Francesco Bifari, Paolo Fiorina, Franco Folli
Background Cardiovascular (CV) risk assessment may result unpractical in real-world clinical practice, although being considered a key step for choosing appropriate therapies for patients with Type 2 Diabetes Mellitus (T2DM). In order to streamline t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6ff8028e93a496341728e56799aa60c
https://doi.org/10.21203/rs.3.rs-2134695/v2
https://doi.org/10.21203/rs.3.rs-2134695/v2
Publikováno v:
Minerva endocrinology. 46(2)
The world population is facing a health challenge never seen since the Spanish influenza of one hundred years ago. During the last months, the scientific community has been debating on the potential harmful effect of angiotensin-converting-enzyme inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2b6696cb34b15fbc1858f6176655b64
https://pubmed.ncbi.nlm.nih.gov/33435650
https://pubmed.ncbi.nlm.nih.gov/33435650
Autor:
Alessandra Gandolfi, Claudia Specchia, Loredana Bucciarelli, Laura Montefusco, Stefano Genovese, Fabio Saponaro, Maura Arosio, Marco Scardapane, Guido Adda, Maria Chiara Rossi, Maurizio Rondinelli, Antonio Rossi, Chiara Molinari
Publikováno v:
Clinical Therapeutics. 39:159-169
Purpose An observational retrospective study was conducted by 2 diabetes clinics in Italy to assess patterns of use and long-term effectiveness of liraglutide on established and emerging parameters. Methods Data from 261 patients with type 2 diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89ec9683d330f847da8f3a41007f873d
https://doi.org/10.1016/j.clinthera.2016.11.001
https://doi.org/10.1016/j.clinthera.2016.11.001
Autor:
Antonio Ceriello, Silvia Canivell, Katherine Esposito, Maurizio Rondinelli, Loredana Bucciarelli, Anna Novials, Roberto Testa, Lucia La Sala, Gemma Pujadas, Stefano Genovese
Publikováno v:
Diabetes Care. 37:1938-1943
OBJECTIVE To test the hypothesis that the simultaneous administration of GLP-1 and insulin may increase their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes. RESEARCH DESIGN AND METHODS In two groups of persons with type 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ecd53a85d0c1a363612f4ea4eb744c3
https://doi.org/10.2337/dc13-2618
https://doi.org/10.2337/dc13-2618
Autor:
Antonio Ceriello, Loredana Bucciarelli, Maurizio Rondinelli, Silvia Canivell, Anna Novials, Emilio Ortega, Lucia La Sala, Stefano Genovese, Gemma Pujadas
Publikováno v:
Diabetes Care
OBJECTIVE To test the hypothesis that acute hypoglycemia induces endothelial dysfunction and inflammation through the generation of an oxidative stress. Moreover, to test if the antioxidant vitamin C can further improve the protective effects of gluc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::857d0f639408989abf58f800bf399f63
https://doi.org/10.2337/dc13-0750
https://doi.org/10.2337/dc13-0750
Autor:
Francesca Santilli, Giovanni Davì, Noemi Michetti, Agostino Consoli, Giovanni Ciabattoni, Patrizia Ferroni, Loredana Bucciarelli, Gloria Formoso, E Devangelio, Cristina Clissa
Publikováno v:
Free Radical Biology and Medicine. 43:511-518
Advanced glycation end products (AGEs) contribute to diabetic vascular complications by engaging the AGE receptor (RAGE). A soluble RAGE form (sRAGE) acts as a decoy domain receptor, thus decreasing AGE cellular binding. A cross-sectional comparison
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61fb013f678cf281279fd1e533d28289
https://doi.org/10.1016/j.freeradbiomed.2007.03.015
https://doi.org/10.1016/j.freeradbiomed.2007.03.015
Autor:
Antonio Ceriello, Roberto Testa, Maurizio Rondinelli, Gemma Pujadas, Valeria De Nigris, Lucia La Sala, Loredana Bucciarelli, Katherine Esposito, Stefano Genovese
Publikováno v:
Cardiovascular Diabetology
Background In type 2 diabetes, acute hyperglycemia worsens endothelial function and inflammation,while resistance to GLP-1 action occurs. All these phenomena seem to be related to the generation of oxidative stress. A Mediterranean diet, supplemented
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4cd19bfbfcbe96d5c42170cff9e8d64
http://hdl.handle.net/11591/331625
http://hdl.handle.net/11591/331625
Publikováno v:
Current medicinal chemistry. 16(8)
The ligand - receptor for advanced glycation end-products (RAGE) axis has emerged as a novel pathway involved in a wide spectrum of diseases, including diabetes mellitus, atherothrombosis, chronic renal failure, rheumatoid arthritis, neurodegeneratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0e60a5c1f0c7cf494a1375147b60b54
https://pubmed.ncbi.nlm.nih.gov/19275604
https://pubmed.ncbi.nlm.nih.gov/19275604